Abstract

This article focuses on the evidence-based treatment of carbon monoxide (CO) poisoning, the most common preventable toxic exposure that results in death in children 12 years old and younger. Evidence suggesting that CO poisoning should be considered in the differential diagnosis of pediatric patients with nonspecific complaints is examined, and the use of carboxyhemoglobin levels to determine severity of CO exposure is reviewed.

Keywords: CO poisoning,  inhalation injury, delayed neurologic sequelae, COHb